| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| RAPT Therapeutics, Inc. | Director | Director Stock Option (right to buy) | 258K | 29 May 2025 | Direct | ||
| Contineum Therapeutics, Inc. | Director | Stock Option (right to buy) | 14.8K | 26 Jun 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| CTNM | Contineum Therapeutics, Inc. | 26 Jun 2025 | 1 | $0 | 4 | Director | 26 Jun 2025, 17:43 |
| RAPT | RAPT Therapeutics, Inc. | 29 May 2025 | 1 | $0 | 4 | Director | 02 Jun 2025, 17:02 |
| CTNM | Contineum Therapeutics, Inc. | 24 May 2024 | 1 | $0 | 4 | Director | 29 May 2024, 17:54 |
| RAPT | RAPT Therapeutics, Inc. | 22 May 2024 | 1 | $0 | 4 | Director | 23 May 2024, 18:16 |
| CTNM | Contineum Therapeutics, Inc. | 04 Apr 2024 | 0 | $0 | 3 | Director | 04 Apr 2024, 17:58 |
| RAPT | RAPT Therapeutics, Inc. | 24 May 2023 | 1 | $0 | 4 | Director | 25 May 2023, 18:57 |
| RAPT | RAPT Therapeutics, Inc. | 25 May 2022 | 1 | $0 | 4 | Director | 26 May 2022, 18:15 |
| RAPT | RAPT Therapeutics, Inc. | 09 Nov 2021 | 1 | $0 | 4 | Director | 10 Nov 2021, 19:22 |
| RAPT | RAPT Therapeutics, Inc. | 09 Nov 2021 | 0 | $0 | 3 | Director | 10 Nov 2021, 19:19 |